hepat sensit effect sulfonylurea drug insulin regul hepat glucos product hgp non-insulin-depend diabet niddm glucos output liver elev plasma glucos concentr basal state restor normal insulin action liver goal hypoglycem therapi sulfonylurea treatment niddm past year addit stimulatori effect insulin secret compound extrapancreat effect earli vitro studi addit sulfonylurea perfus medium liver prepar signific suppress effect hgp subsequ experi compound level insulin receptor variou postreceptor site studi sulfonylurea glycogenolysi gluconeogenesi glycogen synthesi result vivo niddm patient agreement vitro studi long-term treatment sulfonylurea declin plasma glucos concentr parallel reduct hgp nevertheless direct effect sulfonylurea administr liver unclear reduct hgp sulfonylurea treatment secondari overal improv insulin secret interest insulin-depend diabet patient sulfonylurea administr combin insulin inject signific chang hgp possibl effect sulfonylurea glucagon secret metabol free fatti acid ffa improv sensit liver suppress action insulin agent plasma glucagon ffa concentr present data support extrapancreat action sulfonylurea liver certain degre residu insulin secret sulfonylurea agent hepat effect 